A Cross-sectional Study of Cutaneous Immune-Related Adverse Effects in Hispanic Patients after Immune Checkpoint Inhibitor Use for Cancer Therapy
Published: 25 June 2024| Version 1 | DOI: 10.17632/hybj7mvs97.1
Contributors:
Katerina Yale, Jennifer Roux, Jessica ShiuDescription
Figure 1. Flowchart of the study cohort.
Files
Institutions
University of California Irvine
Categories
Dermatology, Psoriasis, Vitiligo, Pemphigoid, Immune Checkpoint Inhibitor